Ticker Details
Forte Biosciences, Inc.
IPO Date:	April 10, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.63B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.67 | 4.62%
Avg Daily Range (30 D):	$1.65 | 3.20%
Avg Daily Range (90 D):	$1.31 | 4.38%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	2.01M
Avg Daily Volume (90 D):	.89M

Trade Size
Avg Trade Size (Sh.):	142
Avg Trade Size (Sh.) (30 D):	158
Avg Trade Size (Sh.) (90 D):	115

Institutional Trades
Total Institutional Trades:	414
Avg Institutional Trade:	$3.43M
Avg Institutional Trade (30 D):	$4.45M
Avg Institutional Trade (90 D):	$4.2M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$4.02M
Avg Closing Trade (30 D):	$4.3M
Avg Closing Trade (90 D):	$4.33M
Avg Closing Volume:	76.26K

News

Aug 6, 2026 @ 11:48 AM argenx Announces Commencement of Tender Offer to A... Source: Na

Aug 5, 2026 @ 7:41 PM Halper Sadeh LLC is Investigating Whether FBRX, LX... Source: Halper Sadeh Llc

Jul 29, 2026 @ 12:05 AM Halper Sadeh LLC is Investigating Whether FBRX and... Source: Halper Sadeh Llc

Aug 14, 2025 @ 5:00 PM Vitiligo Clinical Trial Pipeline Accelerates as 18... Source: Delveinsight

Jul 4, 2025 @ 10:00 AM Forte and Sequence Partner to Power Web3 Monetizat... Source: Bela Pandya (Forte Ceo)

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-4.62	$-.97	$-1.24
Diluted EPS	$-4.62	$-.97	$-1.24
Revenue	$2.72M	$M	$M
Gross Profit
Net Income / Loss	$-87.94M	$-23.33M	$-22.14M
Operating Income / Loss	$-90M	$-24.6M	$-22.44M
Cost of Revenue
Net Cash Flow	$-56.52M	$-27.33M	$M
PE Ratio

Splits
Aug 28, 2024	1:25